The identification of PD is difficult in earlier stages, it goes on at the end the result is not obtained. There is no direct treatment for PD and there is no biopsy reports or scan reports that confirm the diagnosis. At present, there is no cure for PD. Medication is given in 3 stages: Initial stage includes the drug called Levodopa, which increase the monoamine neurotransmitter in the brain, the second stage shows less severe PD symptoms and the third stage will help to manage the non-motor symptoms as well as depression. Magnetic Resonance Imaging and Computed Tomogram are used by many physicians to find out other relating Parkinson’s diseases such as encephalitis, Tumours, Hydrocephalus. Dopamine level release and activity of the brain can easily detect using PET and SPECT examining.
Related: Parkinson’s Conference | Parkinson’s Disease Conference | Parkinson’s Congress | Movement Disorder Conferences | Neuroscience Conferences | Neurology Conferences
Related Conferences:
World Congress on Parkinson’s and Movement Disorders, July 23-24, 2019 at Berlin, Germany | 5th Global Experts Meeting on Parkinson’s, Huntington’s & Movement Disorders, May 08-09, 2019, at Tokyo, Japan | 5th World Parkinson Congress, June 4-7,2019, at Kyoto, Japan | 5th International Conference on Parkinson’s disease and Movement Disorders, October 19-20, 2018, at New York, USA | Movement Disorders in Children and Young Adults, November 22-23, 2018, at Groningen, Netherlands
Related Association and Societies:
American Academy of Neurology; Movement Disorders Society; The International Parkinson and Movement Disorder Society; Canadian Movement Disorders Group; UK Parkinson’s Action Network; European Neurological Society; European Parkinson’s Disease Association; Danish Movement Disorder Society; Italian Society for the study of Parkinson Disease; Extrapyramidal Diseases and Dementia; Movement Disorder Society of Australia; Parkinson’s Disease and Movement Disorders Society of India; Australian Parkinson’s Disease Society; Movement Disorder Society of Japan
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
